Tolga Tanguler
Corporate Officer/Principal presso ALNYLAM PHARMACEUTICALS, INC.
Patrimonio netto: 1 M $ in data 30/04/2024
Posizioni attive di Tolga Tanguler
Società | Posizione | Inizio | Fine |
---|---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 05/01/2021 | - |
Storia della carriera di Tolga Tanguler
Precedenti posizioni note di Tolga Tanguler
Società | Posizione | Inizio | Fine |
---|---|---|---|
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
PFIZER, INC. | Corporate Officer/Principal | - | - |
Ferrosan Holding A/S
Ferrosan Holding A/S Specialty StoresRetail Trade Ferrosan Holding A/S offers science-based consumer healthcare products. It supplies dietary supplements and lifestyle products. The firm also acquires and holds financial assets in Ferrosan A/S. The company was founded on May 1, 1985 and is headquartered in Søborg, Denmark. | Direttore/Membro del Consiglio | - | - |
Formazione di Tolga Tanguler
Michigan State University | Masters Business Admin |
Istanbul University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Danimarca | 2 |
Turchia | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
Masters Business Admin | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Retail Trade | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
PFIZER, INC. | Health Technology |
Aziende private | 2 |
---|---|
Ferrosan Holding A/S
Ferrosan Holding A/S Specialty StoresRetail Trade Ferrosan Holding A/S offers science-based consumer healthcare products. It supplies dietary supplements and lifestyle products. The firm also acquires and holds financial assets in Ferrosan A/S. The company was founded on May 1, 1985 and is headquartered in Søborg, Denmark. | Retail Trade |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Tolga Tanguler
- Esperienza